PFBT
BBIO icon

Parkside Financial Bank & Trust’s BridgeBio Pharma BBIO Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.4K Buy
248
+164
+195% +$11.9K ﹤0.01% 1334
2025
Q4 		$6.43K Hold
84
– – ﹤0.01% 1727
2025
Q3 		$4.36K Hold
84
– – ﹤0.01% 1779
2025
Q2 		$3.63K Buy
84
+24
+40% +$873 ﹤0.01% 1810
2025
Q1 		$2.08K Buy
+60
New +$2.02K ﹤0.01% 1874

Other funds holding BBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's BBIO Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its BridgeBio Pharma (BBIO) stake by 195% in Q1 2026, buying an estimated $11.9K and bringing the position to 248 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1334.

Parkside Financial Bank & Trust first reported a position in BBIO in Q1 2025 and has held it in 5 quarters since. 460 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Parkside Financial Bank & Trust held 248 shares of BridgeBio Pharma worth $18.4K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 164 BridgeBio Pharma shares in Q1 2026, an estimated $11.9K.
  • BridgeBio Pharma made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1334 holding.
  • Parkside Financial Bank & Trust first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 5 quarters since.
  • 460 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.